Country: New Zealand
Language: English
Source: Medsafe (Medicines Safety Authority)
Metformin hydrochloride 250mg
Actavis New Zealand Limited
Metformin hydrochloride 250 mg
250 mg
Coated tablet
Active: Metformin hydrochloride 250mg Excipient: Magnesium stearate Opadry Clear OY-29020 Povidone Water
Blister pack, Al/PVC/PVDC, 10 tablets, 10 tablets
Prescription
Prescription
Wanbury Limited
Package - Contents - Shelf Life: Blister pack, Al/PVC/PVDC - 10 tablets - 3 years from date of manufacture stored at or below 30°C - Blister pack, Al/PVC/PVDC - 100 tablets - 3 years from date of manufacture stored at or below 30°C - Bottle, HDPE bottles with polypropylene screw caps - 10 tablets - 3 years from date of manufacture stored at or below 30°C - Bottle, HDPE bottles with polypropylene screw caps - 100 tablets - 3 years from date of manufacture stored at or below 30°C
2006-06-30
ARROW - METFORMIN Metformin 250 mg, 500 mg, 850 mg and 1000 mg Tablets WHAT IS IN THIS LEAFLET This leaflet answers some common questions about ARROW - METFORMIN. It does not contain all of the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have benefits and risks. Your doctor has weighed the risks of you taking ARROW - METFORMIN against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, TALK TO YOUR DOCTOR, PHARMACIST OR DIABETES EDUCATOR. Keep this leaflet with your medicine. You may need to read it again. WHAT ARROW - METFORMIN IS USED FOR ARROW - METFORMIN Tablets are used to control blood glucose in patients with diabetes mellitus. There are two types of diabetes mellitus: • type 1, also called insulin dependent diabetes mellitus • type 2, also called non-insulin dependent diabetes mellitus or maturity onset diabetes. People with type 2 diabetes are unable to make enough insulin or their body does not respond properly to the insulin it does make. This causes a build up of glucose in the blood, which can lead to serious medical problems. ARROW - METFORMIN is used when diet and exercise are not enough to control your blood glucose levels. ARROW - METFORMIN can be used alone, or in combination with other medicines for treating diabetes. ARROW - METFORMIN can also be used in patients with type 1 diabetes mellitus where insulin alone is not enough to control blood glucose levels. ARROW - METFORMIN is not recommended for use in children except for those with insulin resistant diabetes who are being treated in hospital. Your doctor may, however, prescribe ARROW - METFORMIN for an Read the complete document
ARROW - METFORMIN Metformin Hydrochloride 250 mg, 500 mg, 850 mg and 1000 mg Tablets DESCRIPTION Metformin hydrochloride. The chemical name for metformin hydrochloride is 1,1-dimethylbiguanide hydrochloride. Its structural formula is: C 4 H 11 N 5 .HCl Molecular weight: 165.6 CAS No.: 1115-70-4 Metformin hydrochloride is a white, crystalline powder which is odourless or almost odourless and hygroscopic. It is freely soluble in water, slightly soluble in ethanol (96%), and practically insoluble in chloroform and ether. Arrow - Metformin tablets come in four strengths and contain either 250 mg, 500 mg, 850 mg or 1000 mg of metformin hydrochloride. The tablets also contain the following excipients: povidone, magnesium stearate and Opadry Clear OY-29020. The tablets are gluten free. PRESENTATION Arrow - Metformin 250: 250 mg tablet - round, white tablet, marked with 'MO' on one side and ' ' on the other. Arrow - Metformin 500: 500 mg tablet - oblong, white tablet, marked 'M | O' on one side and " " on the other. Arrow - Metformin 850: 850 mg tablet - round, white tablet, marked 'MO' on one side and ' ' on the other. Arrow - Metformin 1000: 1000 mg tablet - oblong, white tablet, marked 'M | O' on one side and ' | ' on the other. CLINICAL PARTICULARS _ACTIONS _ Arrow - Metformin is an oral biguanide hypoglycaemic agent. It causes an increased peripheral uptake of glucose by increasing the biological efficiency of available exogenous or endogenous insulin. The mode of action of metformin may be linked to an increase of insulin sensitivity. It does not stimulate insulin release but does require the presence of insulin to exert its hypoglycaemic effect. Possible mechanisms of action include inhibition of gluco Read the complete document